Can low progesterone and androgen tone lower the migraine threshold in some women?

The hormonal environment plays a critical role in determining the migraine threshold, particularly through the stabilizing effects of neurosteroids on the central nervous system. For women in their early 30s, the interplay between progesterone, its metabolites, and androgens creates a neurochemical buffer against cortical excitability.

Clinical and effectiveness evidence

The relationship between progesterone and migraine is primarily mediated by its metabolite, allopregnanolone. Clinical research indicates that allopregnanolone levels are significantly lower in women who suffer from menstrually-related migraines compared to those who do not.

• Progesterone influence: Studies show that serum allopregnanolone levels inversely correlate with the number of migraine days ($p < 0.05$). Lower levels are consistently associated with increased migraine frequency and intensity, particularly during the late luteal phase of the menstrual cycle.
• Androgen associations: The role of androgens is emerging but suggests a similar protective effect. In healthy women, higher salivary testosterone levels correlate with reduced pain sensitivity. Some clinical observations suggest that a high estrogen-to-androgen ratio may be a more significant risk factor for migraine than the absolute level of either hormone alone.

Mechanistic explanations

The biological basis for this claim rests on the "disinhibition" of the cerebral cortex when neurosteroid levels fall.

• GABAergic stabilization: Allopregnanolone is a potent positive allosteric modulator of GABA-A receptors. By enhancing the inhibitory effect of GABA, it maintains neuronal hyperpolarization and prevents the spontaneous firing that characterizes an irritable cortex.
• Cortical Spreading Depression (CSD): When progesterone and allopregnanolone levels drop, the loss of GABAergic "tone" increases susceptibility to Cortical Spreading Depression—the electrophysiological wave of depolarization that triggers migraine aura and activates pain pathways.
• Androgen-mediated analgesia: Androgens like testosterone exert anti-inflammatory and analgesic effects. Low androgen tone may reduce the brain's internal "braking system" for pain signals, further lowering the threshold at which a trigger results in a full-blown attack.

Limitations and considerations

While the progesterone-GABA link is robustly supported, the specific contribution of androgens to the migraine threshold in women is considered plausible but requires more large-scale longitudinal data. Most research currently prioritizes estrogen withdrawal as the primary trigger, with progesterone and androgens acting as secondary modulators that determine how sensitive a woman's brain is to that withdrawal.

Bottom line

Low progesterone (via its metabolite allopregnanolone) and low androgen tone reduce the brain's inhibitory GABAergic stability. This state of increased cortical excitability lowers the migraine threshold, making the nervous system more vulnerable to triggers and increasing the likelihood of an attack.